AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Why companies don't want to list in the UK anymore
Behind the Money
Introduction
Sir John Bell is the chair of a British biotech firm called Amunocor. The company got its start in Bell's lab more than 20 years ago. But as the company grew, they needed to find investors. They first looked inside the UK but found funding dried up there. So instead, they turned to investors in the United States where they had better luck. In 2020, their clinical trial data came back showing positive results.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode